Balchem Corp
BCPC156.300USD
-2.420-1.52%
收盘 12/19, 16:00（美东）报价延迟15分钟
5.06B总市值
33.90市盈率 TTM
关于 Balchem Corp 公司
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Balchem Corp简介
公司代码BCPC
公司名称Balchem Corp
上市日期Jun 03, 1986
CEOHarris (Theodore L)
员工数量1361
证券类型Ordinary Share
年结日Jun 03
公司地址- -
城市- -
上市交易所NASDAQ OMX - NASDAQ BASIC
国家- -
邮编- -
电话- -
网址- -
公司代码BCPC
上市日期Jun 03, 1986
CEOHarris (Theodore L)
Balchem Corp公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Theodore L. (Ted) Harris
Mr. Theodore L. (Ted) Harris
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
61.58K
-0.77%
Mr. David B. (Dave) Fischer
Mr. David B. (Dave) Fischer
Independent Director
Independent Director
5.94K
-25.19%
Ms. Hatsuki Miyata
Ms. Hatsuki Miyata
Executive Vice President, Chief Legal Officer and Secretary
Executive Vice President, Chief Legal Officer and Secretary
1.55K
-23.80%
Mr. Frederic Boned
Mr. Frederic Boned
Senior Vice President, General Manager - Human Nutrition and Health
Senior Vice President, General Manager - Human Nutrition and Health
410.00
-78.03%
Mr. Matthew D. (Matt) Wineinger
Mr. Matthew D. (Matt) Wineinger
Lead Independent Director
Lead Independent Director
--
--
Mr. C. Martin Bengtsson
Mr. C. Martin Bengtsson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Ms. Monica Vicente
Ms. Monica Vicente
Independent Director
Independent Director
--
-100.00%
Mr. Olivier Rigaud
Mr. Olivier Rigaud
Independent Director
Independent Director
--
-100.00%
Mr. Daniel E. Knutson, CPA
Mr. Daniel E. Knutson, CPA
Independent Director
Independent Director
--
--
Mr. Martin L. Reid
Mr. Martin L. Reid
Senior Vice President and Chief Supply Chain Officer
Senior Vice President and Chief Supply Chain Officer
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Theodore L. (Ted) Harris
Mr. Theodore L. (Ted) Harris
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
61.58K
-0.77%
Mr. David B. (Dave) Fischer
Mr. David B. (Dave) Fischer
Independent Director
Independent Director
5.94K
-25.19%
Ms. Hatsuki Miyata
Ms. Hatsuki Miyata
Executive Vice President, Chief Legal Officer and Secretary
Executive Vice President, Chief Legal Officer and Secretary
1.55K
-23.80%
Mr. Frederic Boned
Mr. Frederic Boned
Senior Vice President, General Manager - Human Nutrition and Health
Senior Vice President, General Manager - Human Nutrition and Health
410.00
-78.03%
Mr. Matthew D. (Matt) Wineinger
Mr. Matthew D. (Matt) Wineinger
Lead Independent Director
Lead Independent Director
--
--
Mr. C. Martin Bengtsson
Mr. C. Martin Bengtsson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
收入明细
单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Product Sales Revenue
255.04M
99.83%
Royalty
426.00K
0.17%
地区USD
名称
营收
占比
United States
186.71M
73.08%
Foreign Countries
68.76M
26.92%
业务
地区
业务USD
名称
营收
占比
Product Sales Revenue
255.04M
99.83%
Royalty
426.00K
0.17%
股东统计
更新时间: 10月8日 周三
更新时间: 10月8日 周三
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
13.43%
The Vanguard Group, Inc.
12.00%
Conestoga Capital Advisors, LLC
3.93%
State Street Investment Management (US)
3.71%
Wasatch Global Investors Inc
3.34%
其他
63.60%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
13.43%
The Vanguard Group, Inc.
12.00%
Conestoga Capital Advisors, LLC
3.93%
State Street Investment Management (US)
3.71%
Wasatch Global Investors Inc
3.34%
其他
63.60%
股东类型
持股股东
占比
Investment Advisor
51.15%
Investment Advisor/Hedge Fund
28.69%
Hedge Fund
6.00%
Pension Fund
2.43%
Research Firm
1.95%
Sovereign Wealth Fund
1.59%
Bank and Trust
1.04%
Individual Investor
0.54%
Family Office
0.06%
其他
6.56%
机构持股
更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
692
30.08M
92.73%
+17.89K
2025Q3
707
30.06M
92.66%
+267.74K
2025Q2
685
29.78M
92.71%
+58.29K
2025Q1
661
29.74M
93.11%
-556.18K
2024Q4
638
29.76M
94.56%
+6.32K
2024Q3
611
29.83M
94.33%
+196.23K
2024Q2
600
29.66M
94.99%
-187.86K
2024Q1
588
29.84M
94.20%
-559.06K
2023Q4
578
29.57M
93.53%
+265.95K
2023Q3
565
29.33M
93.21%
-102.61K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
4.44M
13.67%
-111.30K
-2.45%
Jun 30, 2025
The Vanguard Group, Inc.
3.89M
11.99%
+47.60K
+1.24%
Jun 30, 2025
Conestoga Capital Advisors, LLC
1.15M
3.54%
-19.03K
-1.63%
Jun 30, 2025
State Street Investment Management (US)
1.23M
3.78%
-1.53K
-0.12%
Jun 30, 2025
Wasatch Global Investors Inc
960.09K
2.96%
-108.92K
-10.19%
Jun 30, 2025
Geode Capital Management, L.L.C.
980.97K
3.02%
+14.33K
+1.48%
Jun 30, 2025
Geneva Capital Management LLC
895.53K
2.76%
+64.72K
+7.79%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
575.40K
1.77%
-18.35K
-3.09%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
469.08K
1.45%
+38.60K
+8.97%
Jun 30, 2025
JP Morgan Asset Management
389.05K
1.2%
-7.19K
-1.82%
Jun 30, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Invesco S&P SmallCap Materials ETF
6.89%
Invesco S&P SmallCap Quality ETF
1.2%
First Trust Horizon Managed Vol Small/Mid ETF
1.05%
ProShares Russell 2000 Dividend Growers ETF
0.91%
Invesco S&P SmallCap Low Volatility ETF
0.87%
State Street SPDR S&P 600 Small Cap Growth ETF
0.68%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.64%
iShares S&P Small-Cap 600 Growth ETF
0.63%
Pacer US Small Cap Cash Cows Growth Leaders ETF
0.57%
Parametric Equity Premium Income ETF
0.56%
查看更多
Invesco S&P SmallCap Materials ETF
占比6.89%
Invesco S&P SmallCap Quality ETF
占比1.2%
First Trust Horizon Managed Vol Small/Mid ETF
占比1.05%
ProShares Russell 2000 Dividend Growers ETF
占比0.91%
Invesco S&P SmallCap Low Volatility ETF
占比0.87%
State Street SPDR S&P 600 Small Cap Growth ETF
占比0.68%
Vanguard S&P Small-Cap 600 Growth Index Fund
占比0.64%
iShares S&P Small-Cap 600 Growth ETF
占比0.63%
Pacer US Small Cap Cash Cows Growth Leaders ETF
占比0.57%
Parametric Equity Premium Income ETF
占比0.56%
分红派息
近5年累计派现
104.59M
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Dec 10, 2025
BCPC.NB Final Cash Dividend of gross USD 0.96 paid on Jan 20, 2026 going ex on Dec 23, 2025
Dec 23, 2025
Jan 20, 2026
Dec 23, 2025
Dec 10, 2024
BCPC.NB Final Cash Dividend of gross USD 0.87 paid on Jan 17, 2025 going ex on Dec 26, 2024
Dec 26, 2024
Jan 17, 2025
Dec 26, 2024
Dec 05, 2023
BCPC.NB Final Cash Dividend of gross USD 0.79 paid on Jan 19, 2024 going ex on Dec 26, 2023
Dec 27, 2023
Jan 19, 2024
Dec 26, 2023
Dec 06, 2022
BCPC.NB Final Cash Dividend of gross USD 0.71 paid on Jan 20, 2023 going ex on Dec 23, 2022
Dec 27, 2022
Jan 20, 2023
Dec 23, 2022
Dec 16, 2021
BCPC.NB Final Cash Dividend of gross USD 0.64 paid on Jan 21, 2022 going ex on Dec 27, 2021
Dec 28, 2021
Jan 21, 2022
Dec 27, 2021
Dec 17, 2020
BCPC.NB Final Cash Dividend of gross USD 0.58 paid on Jan 22, 2021 going ex on Dec 24, 2020
Dec 28, 2020
Jan 22, 2021
Dec 24, 2020
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
常见问题
Balchem Corp的前五大股东是谁？
Balchem Corp 的前五大股东如下：
BlackRock Institutional Trust Company, N.A.持有股份：4.44M，占总股份比例：13.67%。
The Vanguard Group, Inc.持有股份：3.89M，占总股份比例：11.99%。
Conestoga Capital Advisors, LLC持有股份：1.15M，占总股份比例：3.54%。
State Street Investment Management (US)持有股份：1.23M，占总股份比例：3.78%。
Wasatch Global Investors Inc持有股份：960.09K，占总股份比例：2.96%。
BlackRock Institutional Trust Company, N.A.持有股份：4.44M，占总股份比例：13.67%。
The Vanguard Group, Inc.持有股份：3.89M，占总股份比例：11.99%。
Conestoga Capital Advisors, LLC持有股份：1.15M，占总股份比例：3.54%。
State Street Investment Management (US)持有股份：1.23M，占总股份比例：3.78%。
Wasatch Global Investors Inc持有股份：960.09K，占总股份比例：2.96%。
Balchem Corp的前三大股东类型是什么？
Balchem Corp 的前三大股东类型分别是：
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Conestoga Capital Advisors, LLC
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Conestoga Capital Advisors, LLC
有多少机构持有Balchem Corp(BCPC)的股份？
截至2025Q4，共有692家机构持有Balchem Corp的股份，合计持有的股份价值约为30.08M，占公司总股份的92.73%。与2025Q3相比，机构持股有所增加，增幅为0.07%。
哪个业务部门对Balchem Corp的收入贡献最大？
在FY2025Q2，Product Sales Revenue业务部门对Balchem Corp的收入贡献最大，创收255.04M，占总收入的99.83%。
